Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma

For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). R...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2024-02, Vol.130 (3), p.410-420
Hauptverfasser: de Almeida, John R, Su, Jie Susie, Kolarski, Mirko Manojlovic, Truong, Tra, Weinreb, Ilan, Perez-Ordonez, Bayardo, Smith, Stephen M, Hosni, Ali, Patel, Snehal, Valero, Cristina, Xu, Bin, Ghossein, Ronald, Katabi, Nora, Clark, Jonathan, Low, Tsu-Hui Hubert, Gupta, Ruta, Graboyes, Evan M, Davies, Joel, Richardson, Mary, Pasham, Vishu, Jester, Rachel, Goldstein, David P, Huang, Shao Hui, Xu, Wei, O'Sullivan, Brian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 420
container_issue 3
container_start_page 410
container_title Cancer
container_volume 130
creator de Almeida, John R
Su, Jie Susie
Kolarski, Mirko Manojlovic
Truong, Tra
Weinreb, Ilan
Perez-Ordonez, Bayardo
Smith, Stephen M
Hosni, Ali
Patel, Snehal
Valero, Cristina
Xu, Bin
Ghossein, Ronald
Katabi, Nora
Clark, Jonathan
Low, Tsu-Hui Hubert
Gupta, Ruta
Graboyes, Evan M
Davies, Joel
Richardson, Mary
Pasham, Vishu
Jester, Rachel
Goldstein, David P
Huang, Shao Hui
Xu, Wei
O'Sullivan, Brian
description For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals. A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold. A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.
doi_str_mv 10.1002/cncr.35020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2869221791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920610732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</originalsourceid><addsrcrecordid>eNpdkV9LwzAUxYMobk5f_AAS8EWEzpukbZpHmX9hzpcJvpU0TUdGm2xJO9i3t3NzDz5d7rk_Dod7ELomMCYA9EFZ5ccsAQonaEhA8AhITE_REACyKInZ9wBdhLDsV04Tdo4GjPOEkAyGyDzpja7dqtG2xdKWeCNrU8rWOItdhSW2rr_j-ewDh1YujF3gWaRqGYKpjDpyzssaK7kx7RaHdScb1wWsdL0TvTLWNfISnVWyDvrqMEfo6-V5PnmLpp-v75PHaaQYSdqICRCFljwpi1RBGpcJ0WUcq0xpUFywKlW9pojgDATjCa8ynWVFqXWRQswZG6G7ve_Ku3WnQ5s3JuyiSKv7VDnNUkEp4YL06O0_dOk6b_t0ORUUUgKc0Z6631PKuxC8rvKVN43025xAvisg3xWQ_xbQwzcHy65odHlE_z7OfgAoJoEU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920610732</pqid></control><display><type>article</type><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><source>Wiley Free Content</source><source>Wiley Online Library - AutoHoldings Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</creator><creatorcontrib>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</creatorcontrib><description>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, &gt;2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals. A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) &gt;6 cm without ENE (N3a). LN number (1 and &gt;1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (&gt;3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold. A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.35020</identifier><identifier>PMID: 37751180</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer ; Classification ; Lymph nodes ; Oral cancer ; Oral carcinoma ; Oral cavity ; Squamous cell carcinoma</subject><ispartof>Cancer, 2024-02, Vol.130 (3), p.410-420</ispartof><rights>2023 American Cancer Society.</rights><rights>2024 American Cancer Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</citedby><cites>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</cites><orcidid>0000-0002-1546-5033 ; 0000-0003-3397-2888 ; 0000-0003-4638-9835 ; 0000-0003-3766-468X ; 0000-0001-9775-5132</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37751180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Almeida, John R</creatorcontrib><creatorcontrib>Su, Jie Susie</creatorcontrib><creatorcontrib>Kolarski, Mirko Manojlovic</creatorcontrib><creatorcontrib>Truong, Tra</creatorcontrib><creatorcontrib>Weinreb, Ilan</creatorcontrib><creatorcontrib>Perez-Ordonez, Bayardo</creatorcontrib><creatorcontrib>Smith, Stephen M</creatorcontrib><creatorcontrib>Hosni, Ali</creatorcontrib><creatorcontrib>Patel, Snehal</creatorcontrib><creatorcontrib>Valero, Cristina</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Ghossein, Ronald</creatorcontrib><creatorcontrib>Katabi, Nora</creatorcontrib><creatorcontrib>Clark, Jonathan</creatorcontrib><creatorcontrib>Low, Tsu-Hui Hubert</creatorcontrib><creatorcontrib>Gupta, Ruta</creatorcontrib><creatorcontrib>Graboyes, Evan M</creatorcontrib><creatorcontrib>Davies, Joel</creatorcontrib><creatorcontrib>Richardson, Mary</creatorcontrib><creatorcontrib>Pasham, Vishu</creatorcontrib><creatorcontrib>Jester, Rachel</creatorcontrib><creatorcontrib>Goldstein, David P</creatorcontrib><creatorcontrib>Huang, Shao Hui</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>O'Sullivan, Brian</creatorcontrib><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><title>Cancer</title><addtitle>Cancer</addtitle><description>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, &gt;2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals. A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) &gt;6 cm without ENE (N3a). LN number (1 and &gt;1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (&gt;3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold. A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</description><subject>Cancer</subject><subject>Classification</subject><subject>Lymph nodes</subject><subject>Oral cancer</subject><subject>Oral carcinoma</subject><subject>Oral cavity</subject><subject>Squamous cell carcinoma</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkV9LwzAUxYMobk5f_AAS8EWEzpukbZpHmX9hzpcJvpU0TUdGm2xJO9i3t3NzDz5d7rk_Dod7ELomMCYA9EFZ5ccsAQonaEhA8AhITE_REACyKInZ9wBdhLDsV04Tdo4GjPOEkAyGyDzpja7dqtG2xdKWeCNrU8rWOItdhSW2rr_j-ewDh1YujF3gWaRqGYKpjDpyzssaK7kx7RaHdScb1wWsdL0TvTLWNfISnVWyDvrqMEfo6-V5PnmLpp-v75PHaaQYSdqICRCFljwpi1RBGpcJ0WUcq0xpUFywKlW9pojgDATjCa8ynWVFqXWRQswZG6G7ve_Ku3WnQ5s3JuyiSKv7VDnNUkEp4YL06O0_dOk6b_t0ORUUUgKc0Z6631PKuxC8rvKVN43025xAvisg3xWQ_xbQwzcHy65odHlE_z7OfgAoJoEU</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>de Almeida, John R</creator><creator>Su, Jie Susie</creator><creator>Kolarski, Mirko Manojlovic</creator><creator>Truong, Tra</creator><creator>Weinreb, Ilan</creator><creator>Perez-Ordonez, Bayardo</creator><creator>Smith, Stephen M</creator><creator>Hosni, Ali</creator><creator>Patel, Snehal</creator><creator>Valero, Cristina</creator><creator>Xu, Bin</creator><creator>Ghossein, Ronald</creator><creator>Katabi, Nora</creator><creator>Clark, Jonathan</creator><creator>Low, Tsu-Hui Hubert</creator><creator>Gupta, Ruta</creator><creator>Graboyes, Evan M</creator><creator>Davies, Joel</creator><creator>Richardson, Mary</creator><creator>Pasham, Vishu</creator><creator>Jester, Rachel</creator><creator>Goldstein, David P</creator><creator>Huang, Shao Hui</creator><creator>Xu, Wei</creator><creator>O'Sullivan, Brian</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1546-5033</orcidid><orcidid>https://orcid.org/0000-0003-3397-2888</orcidid><orcidid>https://orcid.org/0000-0003-4638-9835</orcidid><orcidid>https://orcid.org/0000-0003-3766-468X</orcidid><orcidid>https://orcid.org/0000-0001-9775-5132</orcidid></search><sort><creationdate>20240201</creationdate><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><author>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer</topic><topic>Classification</topic><topic>Lymph nodes</topic><topic>Oral cancer</topic><topic>Oral carcinoma</topic><topic>Oral cavity</topic><topic>Squamous cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Almeida, John R</creatorcontrib><creatorcontrib>Su, Jie Susie</creatorcontrib><creatorcontrib>Kolarski, Mirko Manojlovic</creatorcontrib><creatorcontrib>Truong, Tra</creatorcontrib><creatorcontrib>Weinreb, Ilan</creatorcontrib><creatorcontrib>Perez-Ordonez, Bayardo</creatorcontrib><creatorcontrib>Smith, Stephen M</creatorcontrib><creatorcontrib>Hosni, Ali</creatorcontrib><creatorcontrib>Patel, Snehal</creatorcontrib><creatorcontrib>Valero, Cristina</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Ghossein, Ronald</creatorcontrib><creatorcontrib>Katabi, Nora</creatorcontrib><creatorcontrib>Clark, Jonathan</creatorcontrib><creatorcontrib>Low, Tsu-Hui Hubert</creatorcontrib><creatorcontrib>Gupta, Ruta</creatorcontrib><creatorcontrib>Graboyes, Evan M</creatorcontrib><creatorcontrib>Davies, Joel</creatorcontrib><creatorcontrib>Richardson, Mary</creatorcontrib><creatorcontrib>Pasham, Vishu</creatorcontrib><creatorcontrib>Jester, Rachel</creatorcontrib><creatorcontrib>Goldstein, David P</creatorcontrib><creatorcontrib>Huang, Shao Hui</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>O'Sullivan, Brian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Almeida, John R</au><au>Su, Jie Susie</au><au>Kolarski, Mirko Manojlovic</au><au>Truong, Tra</au><au>Weinreb, Ilan</au><au>Perez-Ordonez, Bayardo</au><au>Smith, Stephen M</au><au>Hosni, Ali</au><au>Patel, Snehal</au><au>Valero, Cristina</au><au>Xu, Bin</au><au>Ghossein, Ronald</au><au>Katabi, Nora</au><au>Clark, Jonathan</au><au>Low, Tsu-Hui Hubert</au><au>Gupta, Ruta</au><au>Graboyes, Evan M</au><au>Davies, Joel</au><au>Richardson, Mary</au><au>Pasham, Vishu</au><au>Jester, Rachel</au><au>Goldstein, David P</au><au>Huang, Shao Hui</au><au>Xu, Wei</au><au>O'Sullivan, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>130</volume><issue>3</issue><spage>410</spage><epage>420</epage><pages>410-420</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, &gt;2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals. A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) &gt;6 cm without ENE (N3a). LN number (1 and &gt;1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (&gt;3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold. A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37751180</pmid><doi>10.1002/cncr.35020</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1546-5033</orcidid><orcidid>https://orcid.org/0000-0003-3397-2888</orcidid><orcidid>https://orcid.org/0000-0003-4638-9835</orcidid><orcidid>https://orcid.org/0000-0003-3766-468X</orcidid><orcidid>https://orcid.org/0000-0001-9775-5132</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2024-02, Vol.130 (3), p.410-420
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_2869221791
source Wiley Free Content; Wiley Online Library - AutoHoldings Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Cancer
Classification
Lymph nodes
Oral cancer
Oral carcinoma
Oral cavity
Squamous cell carcinoma
title Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T07%3A26%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20novel%20TNM%20staging%20N-classification%20of%20oral%20cavity%20squamous%20cell%20carcinoma&rft.jtitle=Cancer&rft.au=de%20Almeida,%20John%20R&rft.date=2024-02-01&rft.volume=130&rft.issue=3&rft.spage=410&rft.epage=420&rft.pages=410-420&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.35020&rft_dat=%3Cproquest_cross%3E2920610732%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920610732&rft_id=info:pmid/37751180&rfr_iscdi=true